LONDON (ShareCast) - (Sharecast News) - BioPharma Credit has increased the size of its proposed placing to "at least" $200m on the back of investor demand that exceeded its original target.
The life-sciences investment trust announced its intention to raise up $150m via a share placing on Friday. BioPharma said it would issue 146.3m shares at $1.025 per share - a 2.9% premium to its net asset value per share at 30 September.

As a result of the strong demand, BioPharma, in consultation with its joint bookrunners, agreed to increase the target size of its placing to "at least $200m".

Biopharma told investors it planned to use the net proceeds from the fundraiser to acquire further investments, in accordance with the investment policy.

As of 1245 BST, Biopharma's London-listed shares were untraded at $1.06 each.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE